Status:
COMPLETED
Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction
Lead Sponsor:
Tanta University
Conditions:
Lipid Profile
Neonates
Eligibility:
All Genders
1-4 years
Phase:
NA
Brief Summary
The aim of our study will demonstrate the effect of omega 3 supplementation on serum lipid profile level and leptin level in neonates with Intrauterine Growth Restriction( IUGR)
Detailed Description
Intrauterine growth restriction is a major cause of perinatal mortality and morbidity . It is noted to affect approximately 5-15 % of pregnant women. Egypt has one of the highest incidences of Intrau...
Eligibility Criteria
Inclusion
- Any full-term Intrauterine growth restriction (IUGR) neonate
Exclusion
- Preterm neonates
- Who died before feeding was established
- Multiple congenital anomalies including GIT anomalies
- Congenital infection
- Cholestasis
- Infant of diabetic mother (IDM)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05242107
Start Date
June 1 2021
End Date
January 10 2022
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta university
Tanta, Egypt